Suppr超能文献

聚(ADP-核糖)聚合酶(PARP-1)在同源重组中起控制作用。

Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination.

作者信息

Schultz Niklas, Lopez Elena, Saleh-Gohari Nasrollah, Helleday Thomas

机构信息

Department of Genetic and Cellular Toxicology, Arrhenius Laboratory, Stockholm University, S-106 91 Stockholm, Sweden.

出版信息

Nucleic Acids Res. 2003 Sep 1;31(17):4959-64. doi: 10.1093/nar/gkg703.

Abstract

Cells with non-functional poly(ADP-ribose) polymerase (PARP-1) show increased levels of sister chromatid exchange, suggesting a hyper recombination phenotype in these cells. To further investigate the involvement of PARP-1 in homologous recombination (HR) we investigated how PARP-1 affects nuclear HR sites (Rad51 foci) and HR repair of an endonuclease-induced DNA double-strand break (DSB). Several proteins involved in HR localise to Rad51 foci and HR-deficient cells fail to form Rad51 foci in response to DNA damage. Here, we show that PARP-1 mainly does not localise to Rad51 foci and that Rad51 foci form in PARP-1-/- cells, also in response to hydroxyurea. Furthermore, we show that homology directed repair following induction of a site-specific DSB is normal in PARP-1-inhibited cells. In contrast, inhibition or loss of PARP-1 increases spontaneous Rad51 foci formation, confirming a hyper recombination phenotype in these cells. Our data suggest that PARP-1 controls DNA damage recognised by HR and that it is not involved in executing HR as such.

摘要

聚(ADP-核糖)聚合酶1(PARP-1)功能缺失的细胞显示姐妹染色单体交换水平升高,表明这些细胞具有高重组表型。为了进一步研究PARP-1在同源重组(HR)中的作用,我们研究了PARP-1如何影响核HR位点(Rad51灶点)以及核酸内切酶诱导的DNA双链断裂(DSB)的HR修复。几种参与HR的蛋白质定位于Rad51灶点,而HR缺陷细胞在DNA损伤时无法形成Rad51灶点。在此,我们表明PARP-1主要不定位于Rad51灶点,并且在PARP-1基因敲除细胞中也能形成Rad51灶点,同样是对羟基脲的反应。此外,我们表明在PARP-1抑制的细胞中,位点特异性DSB诱导后的同源定向修复是正常的。相反,PARP-1的抑制或缺失会增加自发的Rad51灶点形成,证实了这些细胞中的高重组表型。我们的数据表明,PARP-1控制由HR识别的DNA损伤,并且它本身不参与执行HR。

相似文献

引用本文的文献

2
UBA1 inhibition sensitizes cancer cells to PARP inhibitors.UBA1抑制使癌细胞对PARP抑制剂敏感。
Cell Rep Med. 2024 Dec 17;5(12):101834. doi: 10.1016/j.xcrm.2024.101834. Epub 2024 Dec 2.
4
PARP inhibitors in non-ovarian gynecologic cancers.聚(ADP-核糖)聚合酶抑制剂在非卵巢妇科癌症中的应用
Ther Adv Med Oncol. 2024 Jun 12;16:17588359241255174. doi: 10.1177/17588359241255174. eCollection 2024.
8
PARP inhibitors combined with radiotherapy: are we ready?聚(ADP-核糖)聚合酶抑制剂联合放疗:我们准备好了吗?
Front Pharmacol. 2023 Oct 26;14:1234973. doi: 10.3389/fphar.2023.1234973. eCollection 2023.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验